デフォルト表紙
市場調査レポート
商品コード
1457942

ラボインフォマティクスの世界市場:市場規模・シェア分析 (製品別・提供モード別・コンポーネント別)、産業需要の予測 (~2030年)

Laboratory Informatics Market Size and Share Analysis by Product, Delivery Mode, Component, Industry - Global Industry Demand Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 290 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ラボインフォマティクスの世界市場:市場規模・シェア分析 (製品別・提供モード別・コンポーネント別)、産業需要の予測 (~2030年)
出版日: 2024年02月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 290 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のラボインフォマティクス市場は、2023年には43億7,620万米ドルの規模でしたが、2024~2030年には11.4%のCAGRで成長し、2030年には91億7,660万米ドルに達します。業界の成長は、バイオバンク/バイオリポジトリやバイオテクノロジー・製薬業界における研究開発費の増加とともに、ラボオートメーションに対する需要の急増に大きく関係しています。

クラウドベースのカテゴリーが市場をリード

提供モード別では、クラウドベースのカテゴリーが2023年時点で55%と最大のシェアを占めており、今後もこの傾向は続くと思われます。

北米が最も収益を上げている

地域別では、北米が2023年には約40%のシェアで業界をリードしており、この10年の終わりまでに力強い勢いで成長すると思われます。最先端のITインフラが利用しやすく、デジタルリテラシーが高く、ラボ情報システムの受け入れを後押しする法律があることが、業界成長の主な原動力となっています。

また、医療費の増大や、それを食い止める必要性が、業界全体でLIMSの利用をもたらしました。さらに、定評のある製薬企業の存在と、情報管理と分析に関連する運用コストを管理する必要性の高まりが、業界拡大の主な原動力となっています。

当レポートでは、世界のラボインフォマティクスの市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (数量・金額ベース、2017~2030年)、製品別・提供モード別・コンポーネント別・業種別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響分析
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • ポーターのファイブフォース分析

第6章 世界市場

  • 概要
  • 市場収益:製品別 (2017~2030年)
  • 市場収益:提供モード別 (2017~2030年)
  • 市場収益:コンポーネント別 (2017~2030年)
  • 市場収益:業種別 (2017~2030年)
  • 市場収益:地域別 (2017~2030年)

第7章 北米市場

  • 概要
  • 市場収益:製品別 (2017~2030年)
  • 市場収益:提供モード別 (2017~2030年)
  • 市場収益:コンポーネント別 (2017~2030年)
  • 市場収益:業種別 (2017~2030年)
  • 市場収益:国別 (2017~2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

  • 概要
  • 市場収益:製品別 (2017~2030年)
  • 市場収益:提供モード別 (2017~2030年)
  • 市場収益:コンポーネント別 (2017~2030年)
  • 市場収益:業種別 (2017~2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

  • 市場参入企業とその提供製品/サービスの一覧
  • 主要企業の競合ベンチマーク
  • 主要企業の製品ベンチマーク
  • 最近の戦略展開状況

第30章 企業プロファイル

  • LabVantage Solutions Inc.
  • Thermo Fisher Scientific Inc.
  • STARLIMS Corporation
  • PerkinElmer Inc.
  • LABWORKS LLC
  • Autoscribe Informatics
  • Dassault Systemes SE
  • Agilent Technologies Inc.
  • Cerner Corporation
  • McKesson Corporation

第31章 付録

目次
Product Code: 12880

The laboratory informatics market had a size of USD 4,376.2 million in 2023, which will power at a compound annual growth rate of 11.4% by 2024- 2030, touching USD 9,176.6 million by 2030. The industry growth has a lot to do with the surge in the demand for lab automation, along with biobanks/biorepositories and an increase in research and development spending in the biotech and pharma sectors.

Growth Drivers

The increase in the demand for lab automation will power the acceptance of these systems. Owing to the fast enhancements in molecular genomics and genetic testing procedures, the data produced by labs has quickly increased.

Also, the requirement for automated lab systems will increase as a result of the shift in the preference in the direction of personalized care, increase in numerous cancer genomics investigations, and development in patient engagement needs.

The industry will benefit from the governing authorities' snowballing pressure for the disposition of lab automation systems.

Healthcare processes have turned out to be reproducible and repeatable with the mounting acceptance of process automation and robotics.

The growing usage of high-output technologies has made it likely to assess experimental results more competently, which advances the general efficiency of laboratory operations.

The ECM Category has the Fastest Growth

The ECM category will grow the fastest in the years to come, with a 12% rate in the industry.

The acceptance of ECM is growing as it provides comprehensive and integrated solutions for meeting the rising issues in the healthcare sector.

ECM provides a centralized method for seizing, making, organizing, accessing, and examining the whole ecosystem of knowledge assets, media, and e-documents in a company.

Moreover, companies in the industry offer more than a few services associated with ECM, such as design, consultation, installation, and upkeep of these software solutions.

Cloud-Based Category Leads the Market

On the basis of delivery mode, the cloud-based category had the largest share of 55%, in 2023, and it will continue like this in the years to come as well.

This is for the reason that cloud-deployed LIMs make available space on on-premises computer devices, by stowing vast data amounts offsite, which likewise makes it easier for retrieving it whenever the client requires it.

Cloud-based LIMs can be availed of in three ways, PaaS, IaaS, and SaaS. On the SaaS platform, IBM offers its Watson Analytics services. Additionally, LabVantage Solutions Inc. and Core Informatics provide cloud-based services for LIMS.

North America Makes the Most Revenue

North America leads the industry with about 40% share, in 2023, and it will power at a robust rate by the end of this decade. The accessibility of cutting-edge IT infra, together with high levels of digital literacy and legislation boosting the acceptance of lab information systems, is the key driver for the growth of the industry.

Furthermore, the growing healthcare expenditures and the necessity to stem this surge have brought about the usage of LIMSs across industries. Additionally, the existence of well-established pharma businesses and the mounting requirement to control operational costs associated with info management and analysis are the main drivers for the expansion of the industry.

Competitive Analysis

With an increase in the requirement for COVID-19 tests, clinical labs extended the degree of their operations. In turn, the large number of patients led to challenges in emerging, regulating, and validating novel approaches for testing patients, along with gathering, stowing, examining, and rapidly and precisely reporting massive volumes of patient test data.

LIM is important for coping with the requirement for COVID-19 tests in clinical labs, which encouraged product acceptance during the outbreak of the pandemic.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by delivery mode
    • 1.4.3. Market size breakdown, by component
    • 1.4.4. Market size breakdown, by industry
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
  • 6.3. Market Revenue, by Delivery Mode (2017-2030)
  • 6.4. Market Revenue, by Component (2017-2030)
  • 6.5. Market Revenue, by Industry (2017-2030)
  • 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
  • 7.3. Market Revenue, by Delivery Mode (2017-2030)
  • 7.4. Market Revenue, by Component (2017-2030)
  • 7.5. Market Revenue, by Industry (2017-2030)
  • 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
  • 8.3. Market Revenue, by Delivery Mode (2017-2030)
  • 8.4. Market Revenue, by Component (2017-2030)
  • 8.5. Market Revenue, by Industry (2017-2030)
  • 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
  • 9.3. Market Revenue, by Delivery Mode (2017-2030)
  • 9.4. Market Revenue, by Component (2017-2030)
  • 9.5. Market Revenue, by Industry (2017-2030)
  • 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
  • 10.3. Market Revenue, by Delivery Mode (2017-2030)
  • 10.4. Market Revenue, by Component (2017-2030)
  • 10.5. Market Revenue, by Industry (2017-2030)
  • 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
  • 11.3. Market Revenue, by Delivery Mode (2017-2030)
  • 11.4. Market Revenue, by Component (2017-2030)
  • 11.5. Market Revenue, by Industry (2017-2030)
  • 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
  • 12.3. Market Revenue, by Delivery Mode (2017-2030)
  • 12.4. Market Revenue, by Component (2017-2030)
  • 12.5. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
  • 13.3. Market Revenue, by Delivery Mode (2017-2030)
  • 13.4. Market Revenue, by Component (2017-2030)
  • 13.5. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
  • 14.3. Market Revenue, by Delivery Mode (2017-2030)
  • 14.4. Market Revenue, by Component (2017-2030)
  • 14.5. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
  • 15.3. Market Revenue, by Delivery Mode (2017-2030)
  • 15.4. Market Revenue, by Component (2017-2030)
  • 15.5. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
  • 16.3. Market Revenue, by Delivery Mode (2017-2030)
  • 16.4. Market Revenue, by Component (2017-2030)
  • 16.5. Market Revenue, by Industry (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
  • 17.3. Market Revenue, by Delivery Mode (2017-2030)
  • 17.4. Market Revenue, by Component (2017-2030)
  • 17.5. Market Revenue, by Industry (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
  • 18.3. Market Revenue, by Delivery Mode (2017-2030)
  • 18.4. Market Revenue, by Component (2017-2030)
  • 18.5. Market Revenue, by Industry (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
  • 19.3. Market Revenue, by Delivery Mode (2017-2030)
  • 19.4. Market Revenue, by Component (2017-2030)
  • 19.5. Market Revenue, by Industry (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
  • 20.3. Market Revenue, by Delivery Mode (2017-2030)
  • 20.4. Market Revenue, by Component (2017-2030)
  • 20.5. Market Revenue, by Industry (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
  • 21.3. Market Revenue, by Delivery Mode (2017-2030)
  • 21.4. Market Revenue, by Component (2017-2030)
  • 21.5. Market Revenue, by Industry (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
  • 22.3. Market Revenue, by Delivery Mode (2017-2030)
  • 22.4. Market Revenue, by Component (2017-2030)
  • 22.5. Market Revenue, by Industry (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
  • 23.3. Market Revenue, by Delivery Mode (2017-2030)
  • 23.4. Market Revenue, by Component (2017-2030)
  • 23.5. Market Revenue, by Industry (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
  • 24.3. Market Revenue, by Delivery Mode (2017-2030)
  • 24.4. Market Revenue, by Component (2017-2030)
  • 24.5. Market Revenue, by Industry (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
  • 25.3. Market Revenue, by Delivery Mode (2017-2030)
  • 25.4. Market Revenue, by Component (2017-2030)
  • 25.5. Market Revenue, by Industry (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
  • 26.3. Market Revenue, by Delivery Mode (2017-2030)
  • 26.4. Market Revenue, by Component (2017-2030)
  • 26.5. Market Revenue, by Industry (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
  • 27.3. Market Revenue, by Delivery Mode (2017-2030)
  • 27.4. Market Revenue, by Component (2017-2030)
  • 27.5. Market Revenue, by Industry (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
  • 28.3. Market Revenue, by Delivery Mode (2017-2030)
  • 28.4. Market Revenue, by Component (2017-2030)
  • 28.5. Market Revenue, by Industry (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. LabVantage Solutions Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Thermo Fisher Scientific Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. STARLIMS Corporation
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. PerkinElmer Inc.
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. LABWORKS LLC
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Autoscribe Informatics
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Dassault Systemes SE
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Agilent Technologies Inc.
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Cerner Corporation
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. McKesson Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports